PERSONAL CFO SOLUTIONS, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PERSONAL CFO SOLUTIONS, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$111,000
-51.9%
63,165
-11.2%
0.02%
-48.8%
Q4 2021$231,000
-36.2%
71,165
-21.1%
0.04%
-41.9%
Q3 2021$362,000
+182.8%
90,165
+15.4%
0.07%
+184.6%
Q2 2021$128,000
-14.1%
78,1650.0%0.03%
-18.8%
Q1 2021$149,000
-9.7%
78,165
+6.8%
0.03%
-22.0%
Q4 2020$165,00073,165
-17.0%
0.04%
Q3 2020$0
-100.0%
88,165
+17.3%
0.00%
-100.0%
Q2 2020$157,000
+55.4%
75,165
+17.1%
0.05%
+27.8%
Q1 2020$101,00064,1650.04%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders